# Protalix BioTherapeutics, Inc.: filings

PLX · NYSE · CIK 1006281 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/plx.md) · [Financials](/companies/plx/financials.md) · [Filings](/companies/plx/filings.md) · [Insiders](/companies/plx/insiders.md)

## Reports and events: 397 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 284, 4 151, 10-Q 53, SC 13G/A 42, DEF 14A 23, SC 13G 22, 10-K 18, 3 18, DEFA14A 16, CORRESP 14, UPLOAD 14, 424B5 13, PRE 14A 11, ARS 10, CT ORDER 10, 10-Q/A 8, S-8 8, EFFECT 6, S-3 6, SC 13D/A 5, 10-K/A 3, 4/A 3, 8-K/A 3, SCHEDULE 13G 3, 424B3 2, S-3/A 2, 3/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 11:09 ET | [10-Q](/filings/0001104659-26-094444.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094444 |
| 2026-08-12 | 10:59 ET | [8-K](/filings/0001104659-26-094433.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094433 |
| 2026-06-25 | 20:30 ET | [8-K](/filings/0001104659-26-077790.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-077790 |
| 2026-05-21 | 11:03 ET | [8-K](/filings/0001104659-26-064850.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-064850 |
| 2026-05-13 | 11:06 ET | [10-Q](/filings/0001104659-26-059756.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059756 |
| 2026-05-13 | 10:57 ET | [8-K](/filings/0001104659-26-059749.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059749 |
| 2026-04-30 | 20:30 ET | [DEF 14A](/filings/0001104659-26-053016.md) | Proxy statement, period 2026-06-25 | 0001104659-26-053016 |
| 2026-03-18 | 11:12 ET | [10-K](/filings/0001104659-26-029858.md) | Annual report, period 2025-12-31 | 0001104659-26-029858 |
| 2026-03-18 | 10:56 ET | [8-K](/filings/0001104659-26-029846.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-029846 |
| 2026-03-09 | 11:51 ET | [8-K](/filings/0001104659-26-024975.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-024975 |
| 2026-02-11 | 22:10 ET | [8-K](/filings/0001104659-26-013498.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-013498 |
| 2026-01-30 | 15:09 ET | [8-K](/filings/0001104659-26-008410.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-008410 |
| 2026-01-05 | 11:56 ET | [8-K](/filings/0001104659-26-000393.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-000393 |
| 2025-11-13 | 11:58 ET | [10-Q](/filings/0001104659-25-110824.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110824 |
| 2025-11-13 | 11:54 ET | [8-K](/filings/0001104659-25-110821.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110821 |
| 2025-11-03 | 21:44 ET | [8-K](/filings/0001104659-25-105594.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-105594 |
| 2025-10-17 | 12:08 ET | [8-K](/filings/0001104659-25-100264.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100264 |
| 2025-08-22 | 20:39 ET | [8-K](/filings/0001104659-25-081924.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-081924 |
| 2025-08-14 | 11:05 ET | [10-Q](/filings/0001558370-25-011471.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011471 |
| 2025-08-14 | 10:58 ET | [8-K](/filings/0001558370-25-011468.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011468 |
| 2025-08-01 | 20:30 ET | [8-K](/filings/0001558370-25-009989.md) | 8.01 Other events | 0001558370-25-009989 |
| 2025-07-21 | 13:27 ET | [8-K](/filings/0001558370-25-009308.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-009308 |
| 2025-06-26 | 20:30 ET | [8-K](/filings/0001558370-25-008922.md) | 5.07 Shareholder vote results | 0001558370-25-008922 |
| 2025-05-09 | 11:04 ET | [10-Q](/filings/0001558370-25-007063.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007063 |
| 2025-05-09 | 10:57 ET | [8-K](/filings/0001558370-25-007060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007060 |
| 2025-04-30 | 20:30 ET | [DEF 14A](/filings/0001558370-25-006010.md) | Proxy statement, period 2025-06-26 | 0001558370-25-006010 |
| 2025-04-23 | 20:30 ET | [8-K](/filings/0001558370-25-005275.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-005275 |
| 2025-03-17 | 21:19 ET | [8-K](/filings/0001558370-25-003143.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-003143 |
| 2025-03-17 | 11:18 ET | [10-K](/filings/0001558370-25-003039.md) | Annual report, period 2024-12-31 | 0001558370-25-003039 |
| 2025-03-17 | 10:55 ET | [8-K](/filings/0001558370-25-003036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-003036 |
| 2024-12-31 | 21:30 ET | [8-K](/filings/0001558370-24-016505.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-24-016505 |
| 2024-12-23 | 12:01 ET | [8-K](/filings/0001558370-24-016445.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-016445 |
| 2024-11-14 | 12:03 ET | [10-Q](/filings/0001558370-24-015612.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015612 |
| 2024-11-14 | 11:57 ET | [8-K](/filings/0001558370-24-015608.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015608 |
| 2024-10-25 | 12:27 ET | [8-K](/filings/0001558370-24-013664.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013664 |
| 2024-08-14 | 11:02 ET | [10-Q](/filings/0001558370-24-012134.md) | Quarterly report, period 2024-06-30 | 0001558370-24-012134 |
| 2024-08-14 | 10:56 ET | [8-K](/filings/0001558370-24-012133.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-012133 |
| 2024-06-28 | 21:32 ET | [8-K](/filings/0001558370-24-009567.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-24-009567 |
| 2024-05-10 | 11:20 ET | [10-Q](/filings/0001558370-24-007695.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007695 |
| 2024-05-10 | 10:59 ET | [8-K](/filings/0001558370-24-007692.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007692 |
| 2024-04-29 | 20:30 ET | [DEF 14A](/filings/0001104659-24-054084.md) | Proxy statement, period 2024-06-27 | 0001104659-24-054084 |
| 2024-03-14 | 11:03 ET | [10-K](/filings/0001558370-24-003161.md) | Annual report, period 2023-12-31 | 0001558370-24-003161 |
| 2024-03-14 | 10:57 ET | [8-K](/filings/0001558370-24-003160.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-003160 |
| 2023-12-26 | 11:56 ET | [8-K](/filings/0001558370-23-020006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-020006 |
| 2023-11-06 | 12:50 ET | [10-Q](/filings/0001558370-23-017664.md) | Quarterly report, period 2023-09-30 | 0001558370-23-017664 |
| 2023-11-06 | 12:22 ET | [8-K](/filings/0001558370-23-017657.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-017657 |
| 2023-09-12 | 10:58 ET | [8-K](/filings/0001558370-23-015635.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-23-015635 |
| 2023-08-07 | 11:02 ET | [10-Q](/filings/0001558370-23-013483.md) | Quarterly report, period 2023-06-30 | 0001558370-23-013483 |
| 2023-08-07 | 10:59 ET | [8-K](/filings/0001558370-23-013481.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-013481 |
| 2023-07-13 | 20:41 ET | [8-K](/filings/0001558370-23-011868.md) | 5.07 Shareholder vote results | 0001558370-23-011868 |

Page 1 of 8. [Older](/companies/plx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.